Drug Royalty Interest
Longevity & Biotech Royalties
Definition
A drug royalty interest is a contractual right to receive a share of revenue, royalties, milestones, or other payments tied to a pharmaceutical or biotech product.
Why it matters
Drug royalties can provide long-duration cash flow, but exposure depends on patent life, clinical outcomes, payer coverage, competition, manufacturing, and sales concentration.
Common misconceptions
- •Approved drugs still carry commercial, reimbursement, and patent litigation risk.
- •A royalty percentage is not enough; the base, deductions, and payment waterfall matter.
Technical details
Underwriting
Review indication size, clinical data, regulatory status, patent estate, exclusivity, competitive pipeline, payer mix, sales trajectory, and sponsor credit.
Contract Terms
Key terms include royalty base, deductions, audit rights, step-downs, minimums, sublicensing treatment, territory, term, and reporting obligations.